Literature DB >> 1658155

In vitro activation of neutrophils of the aged by recombinant human growth hormone.

C J Wiedermann1, M Niedermühlbichler, H Beimpold, H Braunsteiner.   

Abstract

Several functions of polymorphonuclear neutrophils (PMNL) have been found to be altered in the aged. As the neuroendocrine network, in particular growth hormone (GH), may interfere with the regulation of nonspecific host defense mechanisms, a recently described PMNL-priming activity of recombinant human (rH) GH in vitro was investigated. Oxidative metabolism of PMNL from young and old subjects was studied by measuring reduction of nitroblue tetrazolium (NBT) or cytochrome c. In the absence of stimulating agents, PMNL from old subjects reduced NBT to a significantly lesser extent than did PMNL from young subjects. Addition of rHGH to PMNL from old subjects reversed the suppressed spontaneous oxidative metabolism. No differences between young and old were observed for the increase of stimulated oxidative metabolism. The results suggest that altered PMNL function in the aged may be reversed by rHGH and that the ability of PMNL to respond to rHGH does not decline with age.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658155     DOI: 10.1093/infdis/164.5.1017

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Superoxide anion release from neutrophils in growth hormone deficient adults before and after replacement therapy with recombinant human growth hormone.

Authors:  N Reinisch; P Schratzberger; G Finkenstedt; C M Kähler; C J Wiedermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

Review 2.  Postsurgical complications in older patients. The role of pharmacological intervention.

Authors:  G Zuccalà; A Cocchi; G Gambassi; R Bernabei; P Carbonin
Journal:  Drugs Aging       Date:  1994-12       Impact factor: 3.923

3.  Inhibition of superoxide anion release from circulating neutrophils by L-arginine in man.

Authors:  C J Wiedermann; B Sitte; U Zilian; N Reinisch; H Beimpold; G Finkenstedt; H Braunsteiner
Journal:  Clin Investig       Date:  1993-12

4.  Inhibition of recombinant human growth hormone-induced and prolactin-induced activation of neutrophils by octreotide.

Authors:  C J Wiedermann; N Reinisch; M Niedermühlbichler; H Braunsteiner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

5.  Reduction in superoxide anion secretion and bactericidal activity of neutrophils from aged rats: reversal by the combination of gamma interferon and growth hormone.

Authors:  Y K Fu; S Arkins; Y M Li; R Dantzer; K W Kelley
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

6.  In vivo administration of recombinant growth hormone or gamma interferon activities macrophages: enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates.

Authors:  C K Edwards; S M Ghiasuddin; L M Yunger; R M Lorence; S Arkins; R Dantzer; K W Kelley
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.